ID: ALA4577064

Max Phase: Preclinical

Molecular Formula: C20H16N2O3

Molecular Weight: 332.36

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1ccc2c(c1)C1c3ccccc3C2C2C(=O)NC(=O)C12

Standard InChI:  InChI=1S/C20H16N2O3/c1-9(23)21-10-6-7-13-14(8-10)16-12-5-3-2-4-11(12)15(13)17-18(16)20(25)22-19(17)24/h2-8,15-18H,1H3,(H,21,23)(H,22,24,25)

Standard InChI Key:  GUUBZYJUXOVCNT-UHFFFAOYSA-N

Associated Targets(Human)

Voltage-gated calcium channel 146 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ileum 856 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Aorta 327 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Right atrium 265 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Left atrium 264 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.36Molecular Weight (Monoisotopic): 332.1161AlogP: 2.12#Rotatable Bonds: 1
Polar Surface Area: 75.27Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.40CX Basic pKa: CX LogP: 1.38CX LogD: 1.38
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: -0.47

References

1. Bisi A, Arribas RL, Micucci M, Budriesi R, Feoli A, Castellano S, Belluti F, Gobbi S, de Los Rios C, Rampa A..  (2019)  Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment.,  163  [PMID:30530190] [10.1016/j.ejmech.2018.12.003]

Source